Research ExplorerPublicationsSuccessful mTOR inhibitor therapy for a metastastic neuroend...

Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation

Standard

Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation. / Schrader, J; Henes, F O; Perez, D; Burdak-Rothkamm, S; Stein, A; Izbicki, J R; Lohse, A W.

In: ANN ONCOL, Vol. 28, No. 4, 01.04.2017, p. 904-905.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Schrader, J, Henes, FO, Perez, D, Burdak-Rothkamm, S, Stein, A, Izbicki, JR & Lohse, AW 2017, 'Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation', ANN ONCOL, vol. 28, no. 4, pp. 904-905. https://doi.org/10.1093/annonc/mdx007

APA

Schrader, J., Henes, F. O., Perez, D., Burdak-Rothkamm, S., Stein, A., Izbicki, J. R., & Lohse, A. W. (2017). Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation. ANN ONCOL, 28(4), 904-905. https://doi.org/10.1093/annonc/mdx007

Vancouver

Schrader J, Henes FO, Perez D, Burdak-Rothkamm S, Stein A, Izbicki JR et al. Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation. ANN ONCOL. 2017 Apr 1;28(4):904-905. https://doi.org/10.1093/annonc/mdx007

Bibtex

@article{8e0e41dfab9a4c53afdb846aaa91f42d,
title = "Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation",
keywords = "Journal Article",
author = "J Schrader and Henes, {F O} and D Perez and S Burdak-Rothkamm and A Stein and Izbicki, {J R} and Lohse, {A W}",
note = "Letter",
year = "2017",
month = apr,
day = "1",
doi = "10.1093/annonc/mdx007",
language = "English",
volume = "28",
pages = "904--905",
journal = "ANN ONCOL",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation

AU - Schrader, J

AU - Henes, F O

AU - Perez, D

AU - Burdak-Rothkamm, S

AU - Stein, A

AU - Izbicki, J R

AU - Lohse, A W

N1 - Letter

PY - 2017/4/1

Y1 - 2017/4/1

KW - Journal Article

U2 - 10.1093/annonc/mdx007

DO - 10.1093/annonc/mdx007

M3 - Other (editorial matter etc.)

C2 - 28327903

VL - 28

SP - 904

EP - 905

JO - ANN ONCOL

JF - ANN ONCOL

SN - 0923-7534

IS - 4

ER -